Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-08-09
2010-12-28
Fetterolf, Brandon J (Department: 1628)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S227500, C514S228800, C514S238800
Reexamination Certificate
active
07858610
ABSTRACT:
(1) A preventive and/or a remedy for lower urinary tract diseases such as inflammation in the lower urinary tract, cystitis (interstitial cystitis, etc.) and urethritis; (2) an agent for improving bladder compliance and/or bladder capacity; and (3) an agent for protecting bladder mucosa and/or bladder epithelial cells and/or promoting the regeneration thereof; each containing an EP4agonist.An EP4agonist is useful in ameliorating symptoms of lower urinary tract diseases such as (1) frequent urination, (2) urgency of urination, (3) pain in the reproductive organs and/or lower urinary tract (for example, bladder pain, urinary tract pain, vulvar pain, vaginal pain, scrotal pain, perineal pain, pelvic pain, etc.) and/or (4) discomfort in the reproductive organs and/or lower urinary tract. Among all, a selective EP4agonist is useful as a preventive and/or remedy for lower urinary tract diseases having no side effect.
REFERENCES:
patent: 6462081 (2002-10-01), Maruyama et al.
patent: 6835752 (2004-12-01), Tani et al.
patent: 2003/0216381 (2003-11-01), Tani et al.
patent: 2004/0235825 (2004-11-01), Tani et al.
patent: 2005/0020686 (2005-01-01), Maruyama et al.
patent: 2005/0026908 (2005-02-01), Tani et al.
patent: 2006/0100195 (2006-05-01), Maruyama et al.
patent: 2006/0258728 (2006-11-01), Tani et al.
patent: 00/03980 (2000-01-01), None
patent: 02/16311 (2002-02-01), None
patent: 03/009872 (2003-02-01), None
patent: 03/016254 (2003-02-01), None
patent: 03/043655 (2003-05-01), None
Hurst. Identification of proteoglycans present at high density on bovine and human bladder luminal surface. World J Urol, 12(1):3-10, 1994.
Takahashi et al. EP4 receptor mediation of prostaglandin E2-stimulated mucus secretion by rabbit gastric epithelial cells. Biochem Pharmacol 58:1997-2002, 1999.
Maruyama et al (Bioorg Med Chem 10:1743-1759, 2002).
Kelly et al (Eur Urol 34:53-56, 1998).
Dell and Parsons (J Reprod Med 49:243-252, 2004).
Li et al (Neurosci Lett 438:210-215, 2008).
Han (Advances in Characterization of Pharmaceutical Hydrates. Trends in Bio/Pharmaceutical Industry, pp. 25-29. Mar. 2006).
Vippagunta et al (Adv Drug Deliv Rev 48:3-26, 2001).
Stella et al (Prodrugs: Challenges and Rewards, Part 1, 2007).
Fossaluzza et al.; “Misoprostol-induced Urinary Incontinence”; Journal of Internal Medicine; No. 230: pp. 463-464; 1991.
Maruyama Takayuki
Okada Hiroki
Fetterolf Brandon J
Ono Pharmaceutical Co. Ltd.
Ricci Craig
Sughrue & Mion, PLLC
LandOfFree
Preventive and/or remedy for lower urinary tract diseases... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Preventive and/or remedy for lower urinary tract diseases..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Preventive and/or remedy for lower urinary tract diseases... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4207732